Insiders Moberg Pharma AB

Equities

Delayed Nasdaq Stockholm Other stock markets 08:14:07 15/05/2024 BST			5-day change	1st Jan Change
27.94 ^SEK	-0.36%		-27.40%	+84.47%

05-07	Moberg Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-06	Moberg Pharma AB Announces MOB-015 Receives National Approvals for All Countries Included in the Decentralized Procedure	CI

Moberg Pharma Announces Leadership Changes	11-07	CI
Moberg Pharma AB Appoints Nomination Committee	17/10/23	CI
Moberg Pharma AB Elects Håkan Wallin to the Board Members	16/05/23	CI
Moberg Pharma AB Appoints Anders Bröijersén as Chief Medical Officer and a Member of the Management Team	08/11/22	CI
Moberg Pharma's nomination committee appointed	03/11/22	AQ
Moberg Pharma AB Approves Board Appointments	16/05/22	CI
Peter Wolpert and Fredrik Granström Step-Down from the Board	10/05/22	CI
Moberg Pharma AB Announces Composition of Nomination Committee	12/04/22	CI
The Nomination Committee's proposal to the Annual General Meeting 2022	01/02/22	AQ
Moberg Pharma AB Announces Peter Wolpert and Fredrik Granström are Not Available for Re-Election	01/02/22	CI
Moberg Pharma Chairman to Step Down in May 2022	06/12/21	MT
Moberg Pharma's Chairman Peter Wolpert Not Available for Re-Election	06/12/21	CI
Moberg Pharma : nomination committee appointed	22/10/21	AQ
Moberg Pharma : nomination committee appointed	22/10/21	PU
Moberg Pharma AB Appoints Agneta Larhedas as Vice President Pharmaceutical Innovation & Development	23/06/21	CI
Moberg Pharma AB Elects Nikolaj Sörensen as Director	18/05/21	CI
Moberg Pharma : nomination committee appointed	05/11/20	PU
Moberg Pharma : nomination committee appointed	05/11/20	AQ
Moberg Pharma AB Appoints Nomination Committee	05/11/20	CI
Moberg Pharma AB Appoints Cindy Wong as Chief Medical Officer	30/07/20	CI

No results for this search